This site is intended for health professionals only

Published on 20 March 2008

Share this story:
Twitter
LinkedIn

Health economics of treating multidrug-resistant Gram-positive infections: a qualitative critique

teaser

This review considers analyses undertaken on the economic impact of healthcare-acquired infections and the pharmacoeconomic impact of new drug therapies, including antibiotics such as linezolid

Dilip Nathwani
MB FRCP DTM&H

Consultant Physician and Honorary Professor

Infection Unit
Ninewells Hospital and Medical School
Dundee
UK

SENTRY antimicrobial programme data for 1997



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn